TOKYO, JAPAN - Medical & Biological Laboratories Co., Ltd. (President: Kimimasa Yamada) released the SARS-CoV-2 antigen test kit "GLINE-2019-nCoV Ag kit", which was approved for manufacturing and marketing in Japan on February 10, 2022. We donated 20,000 kits to Ina City, Nagano Prefecture, where our research and production facilities are located.
On March 3, 2022, Kimimasa Yamada, President and CEO of MBL, donated 20,000 kits of SARS-CoV-2 antigen test kit "GLINE-2019-nCoV Ag kit" to Ina City. He received a letter of appreciation from Mayor Shirotori.
Contact details
-
Download vCard
- Missy Bindseil
-
JSR Life Sciences Company Inquiries
Director, Marketing & Communications - mbindseil@jsr-nahq.com
Related topics
Related news
Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanes...
Crown Bioscience and MBL announce the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
MBL Launches Five-test Kit for Rapid SARS-CoV-2 Antigen Detection
This product is a five-test kit version of GLINE-2019-nCoV Ag Kit (Code No. YH-G86256) which was released on February 14th as a one test kit
Launch of a New Kit for the Detection of Anti-Integrin αvβ6 Antibodies for Understanding Patholog...
Anti-integrin αvβ6 antibodies are detected in about 90% of UC patients, and the results of basic research suggest that these autoantibodies themselves may be causing the disease
Acquisition of Manufacturing and Marketing Approval for SARS-CoV-2 Antigen Rapid Test and Release...
With a simple operation, the presence or absence of the SARS-CoV-2 antigen can be determined in 15 minutes